Quantcast

Latest Pharmaceuticals policy Stories

2014-08-06 16:28:59

-- Transformational H1 2014 includes presentation of Phase 3 ASCEND data, NDA resubmission and target PDUFA date of Nov. 23 for pirfenidone in U.S. - BRISBANE, Calif., Aug. 6, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the second quarter ended June 30, 2014. The company also highlighted recent clinical development and business highlights, and updated its forward-looking financial guidance for 2014. InterMune reported Esbriet(®)...

2014-08-06 16:28:44

Safe Pharmacies Prevent Fraud and Abuse WASHINGTON, Aug. 6, 2014 /PRNewswire-USNewswire/ -- A new report by the Health and Human Services Office of Inspector General (HHS-OIG), "Part D Beneficiaries With Questionable Utilization Patterns for HIV Drugs," calling for a pharmacy "lock in" program in Medicare Part D would help decrease prescription drug abuse, the Pharmaceutical Care Management Association (PCMA) said today. "This report confirms the value of establishing safe pharmacy...

2014-08-06 12:28:22

Local Pharmacy and Mail-In Pharmacy Offer Their Service to August 9th Madison Free Clinic MADISON, Wis., Aug. 6, 2014 /PRNewswire/ -- Madison local pharmacy, Society of St. Vincent de Paul, and mail-in pharmacy, RX Outreach have both offered their services and will be providing free prescriptions to patients attending the one-day free health clinic in Madison, on August 9th, sponsored by the National Association of Free and Charitable Clinics....

2014-08-06 08:21:02

Leveraging UPS's global transportation and logistics capabilities, MedVantx creates innovative supply chain solution for the healthcare industry SAN DIEGO, Aug. 6, 2014 /PRNewswire/ -- MedVantx, Inc., a leading provider of medication access, adherence and direct-to-patient consumer programs, today announced it will create a specialty pharmacy on-site at the UPS Global Healthcare campus and adjacent to UPS Worldport, UPS's worldwide air hub located at Louisville International Airport...

2014-08-05 23:03:14

OMICS Group International schedules its 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during September 29 to October 01, 2014 at Baltimore, USA with an aim to Revolutionize the Next Generation Medicines using innovative Bioavailability and Bioequivalence (BA/BE) approaches and Studies. Los Angeles, CA (PRWEB) August 05, 2014 Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile...

2014-08-05 20:22:47

MOUNT PROSPECT, Ill., Aug. 5, 2014 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy(®) (NABP(®)) welcomed domestic and international stakeholders last week for a meeting of the .Pharmacy Supporter Advisory Committee. The committee's guidance is an important part of operationalizing the new .pharmacy generic Top-Level Domain (gTLD). Members of the committee, which is composed of representatives of domestic and international regulatory agencies and patient...

2014-08-05 16:27:45

Jazz Pharmaceuticals owns worldwide rights to defibrotide DUBLIN, Aug. 5, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of rights to defibrotide in the United States (U.S.) and all other countries in the Americas from Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau). Jazz Pharmaceuticals now owns worldwide rights to defibrotide. Defibrotide is a novel product that is marketed by Jazz Pharmaceuticals in the European Union (EU)...

2014-08-05 12:06:50

Boston University Medical Center Study compared warning and withdrawal rates for drugs released before and after the drug industry increased funding to the FDA to expedite drug approvals What's safer: a newly approved drug or one that has been on the market much longer? Newer drugs have a one in three chance of acquiring a black box warning or being withdrawn for safety reasons within 25 years of their approval, according to a new study by researchers from Cambridge Health Alliance...

2014-08-05 08:34:40

Express Scripts' Medical Benefit Management Reduces Overall Specialty Drug Spend ST. LOUIS, Aug. 5, 2014 /PRNewswire/ -- Next year, U.S. health plan sponsors are projected to spend $9.07 billion on specialty medication services that provide no additional value, according to a new analysis released today by Express Scripts (NASDAQ: ESRX). This wasteful spending could be avoided if payers applied cost-saving techniques from the pharmacy benefit on medications that are administered through the...

2014-08-05 08:33:19

SAN FRANCISCO, Aug. 5, 2014 /PRNewswire/ -- Perlstein Lab PBC, a San Francisco-based public benefit corporation whose mission is precision orphan drug discovery, just closed a $2 million seed round. The round was co-led by the clinical-stage orphan drug developer Retrophin, Inc. and the Wilsey family, which is personally affected by an orphan disease. http://photos.prnewswire.com/prnvar/20140805/133384 One in 12 people suffer from an orphan disease, yet 95% of orphan diseases have...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related